DiaMedica Therapeutics (DMAC) Prepaid Assets (2017 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Prepaid Assets came in at $731000.0 in Q1 2026, up 12.63% year-on-year from $649000.0 in Q1 2025, and up 51.98% quarter-over-quarter from $481000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Prepaid Assets (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics' Prepaid Assets history runs 10 years deep, the most recent figure standing at $731000.0 for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 12.63% year-over-year to $731000.0 in Q1 2026; TTM through Mar 2026 was $731000.0, a 12.63% increase from a year earlier, with the FY2025 full-year figure at $481000.0, up 111.89% from the prior year.
- Prepaid Assets climbed to $731000.0 in Q1 2026 per DMAC's latest filing, from $481000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $962000.0 in Q1 2023 and bottomed at $209000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $534000.0 (2022), against an average of $525411.8.
- Across the five-year window, Prepaid Assets surged 148.81% in 2022 and slumped 44.77% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $209000.0 in 2022, then surged by 96.65% to $411000.0 in 2023, then slumped by 44.77% to $227000.0 in 2024, then jumped by 111.89% to $481000.0 in 2025, then surged by 51.98% to $731000.0 in 2026.
- Per Business Quant, the three latest DMAC Prepaid Assets figures stand at $731000.0 (Q1 2026), $481000.0 (Q4 2025), and $445000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 731,000.00 |
| Dec 31, 2025 | 481,000.00 |
| Sep 30, 2025 | 445,000.00 |
| Jun 30, 2025 | 680,000.00 |
| Mar 31, 2025 | 649,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 568,000.00 |
| Mar 31, 2024 | 569,000.00 |
| Dec 31, 2023 | 411,000.00 |
| Sep 30, 2023 | 396,000.00 |
| Jun 30, 2023 | 675,000.00 |
| Mar 31, 2023 | 962,000.00 |
| Dec 31, 2022 | 209,000.00 |
| Sep 30, 2022 | 322,000.00 |
| Jun 30, 2022 | 534,000.00 |
| Mar 31, 2022 | 793,000.00 |
| Dec 31, 2021 | 84,000.00 |
| Sep 30, 2021 | 336,000.00 |
| Jun 30, 2021 | 318,000.00 |